Home LiteratureArticle Details
PMID: 9221750 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate immune system.

The Journal of experimental medicine ·Vol. 186 ·No. 2 ·1997-07-21 ·Pages 209-20

Niedermann G, Grimm R, Geier E, Maurer M, Realini C, Gartmann C, Soll J, Omura S, Rechsteiner MC, Baumeister W, Eichmann K

Abstract

To generate peptides for presentation by major histocompatibility complex (MHC) class I molecules to T lymphocytes, the immune system of vertebrates has recruited the proteasomes, phylogenetically ancient multicatalytic high molecular weight endoproteases. We have previously shown that many of the proteolytic fragments generated by vertebrate proteasomes have structural features in common with peptides eluted from MHC class I molecules, suggesting that many MHC class I ligands are direct products of proteasomal proteolysis. Here, we report that the processing of polypeptides by proteasomes is conserved in evolution, not only among vertebrate species, but including invertebrate eukaryotes such as insects and yeast. Unexpectedly, we found that several high copy ligands of MHC class I molecules, in particular, self-ligands, are major products in digests of source polypeptides by invertebrate proteasomes. Moreover, many major dual cleavage peptides produced by invertebrate proteasomes have the length and the NH2 and COOH termini preferred by MHC class I. Thus, the ability of proteasomes to generate potentially immunocompetent peptides evolved well before the vertebrate immune system. We demonstrate with polypeptide substrates that interferon gamma induction in vivo or addition of recombinant proteasome activator 28alpha in vitro alters proteasomal proteolysis in such a way that the generation of peptides with the structural features of MHC class I ligands is optimized. However, these changes are quantitative and do not confer qualitatively novel characteristics to proteasomal proteolysis. The data suggest that proteasomes may have influenced the evolution of MHC class I molecules.

MeSH Terms
Acetylcysteine/analogs & derivatives,pharmacology Amino Acid Sequence Animals Binding Sites Cell Line Cysteine Endopeptidases/physiology Histocompatibility Antigens Class I/metabolism Humans Immunocompetence Interferon-gamma/biosynthesis Ligands Molecular Sequence Data Multienzyme Complexes/physiology Peptide Fragments/metabolism Proteasome Endopeptidase Complex Rabbits
Chemicals
Histocompatibility Antigens Class I Ligands Multienzyme Complexes Peptide Fragments lactacystin Interferon-gamma Cysteine Endopeptidases Proteasome Endopeptidase Complex Acetylcysteine
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Niedermann G
Max-Planck-Institut für Immunbiologie, 79108 Freiburg, Germany.
Grimm R
Geier E
Maurer M
Realini C
Gartmann C
Soll J
Omura S
Rechsteiner M C
Baumeister W
Eichmann K
References (67)
67 references, click to expand
  1. The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells.
    Eur J Immunol. 1997 Jan;27(1):336-41 PMID: 9022037
  2. Chromosomal duplication and the emergence of the adaptive immune system.
    Trends Genet. 1997 Mar;13(3):90-2 PMID: 9066265
  3. Primary structures of two homologous subunits of PA28, a gamma-interferon-inducible protein activator of the 20S proteasome.
    FEBS Lett. 1995 Jun 5;366(1):37-42 PMID: 7789512
  4. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes.
    Nature. 1993 Sep 16;365(6443):264-7 PMID: 8396732
  5. Heat shock proteins transfer peptides during antigen processing and CTL priming.
    Immunogenetics. 1994;39(2):93-8 PMID: 8276462
  6. MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation.
    J Immunol. 1994 Feb 1;152(3):1163-70 PMID: 8301122
  7. PA28 activator protein forms regulatory caps on proteasome stacked rings.
    J Mol Biol. 1994 Feb 11;236(1):7-15 PMID: 8107126
  8. Human transporters associated with antigen processing possess a promiscuous peptide-binding site.
    Immunity. 1994 Apr;1(1):7-14 PMID: 7889401
  9. MHC ligands and peptide motifs: first listing.
    Immunogenetics. 1995;41(4):178-228 PMID: 7890324
  10. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules.
    Immunity. 1995 Mar;2(3):289-99 PMID: 7535183
  11. Cooperative interaction of B lymphocytes with antigen-specific helper T lymphocytes is MHC restricted.
    Nature. 1981 Aug 6;292(5823):547-9 PMID: 6166872
  12. The LMP antigens: a stable MHC-controlled multisubunit protein complex.
    Hum Immunol. 1986 Apr;15(4):416-26 PMID: 3700147
  13. Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells.
    J Antibiot (Tokyo). 1991 Jan;44(1):113-6 PMID: 1848215
  14. A hypothetical model for the peptide binding domain of hsp70 based on the peptide binding domain of HLA.
    EMBO J. 1991 May;10(5):1053-9 PMID: 2022182
  15. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.
    Nature. 1991 May 23;351(6324):290-6 PMID: 1709722
  16. Which came first, MHC class I or class II?
    Immunogenetics. 1991;33(5-6):295-300 PMID: 2050387
  17. Proteasome and its novel endogeneous activator in human platelets.
    Biochem Biophys Res Commun. 1991 Jul 15;178(1):256-62 PMID: 2069566
  18. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation.
    Nature. 1991 Sep 26;353(6342):321-5 PMID: 1922337
  19. Exact prediction of a natural T cell epitope.
    Eur J Immunol. 1991 Nov;21(11):2891-4 PMID: 1718764
  20. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry.
    Science. 1992 Mar 6;255(5049):1261-3 PMID: 1546328
  21. Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain).
    J Biol Chem. 1992 May 25;267(15):10515-23 PMID: 1587832
  22. Expression of functional Thermoplasma acidophilum proteasomes in Escherichia coli.
    FEBS Lett. 1992 Nov 9;312(2-3):157-60 PMID: 1426246
  23. Purification of an 11 S regulator of the multicatalytic protease.
    J Biol Chem. 1992 Nov 5;267(31):22369-77 PMID: 1429590
  24. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules.
    Nature. 1992 Nov 12;360(6400):171-4 PMID: 1436094
  25. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation.
    Nature. 1992 Nov 12;360(6400):174-7 PMID: 1299222
  26. Cleavage specificity and inhibition profile of proteasome isolated from the cytosol of Xenopus oocyte.
    J Biochem. 1993 Feb;113(2):225-8 PMID: 8468328
  27. A prominent natural H-2 Kd ligand is derived from protein tyrosine kinase JAK1.
    Immunol Lett. 1993 Mar;35(3):235-7 PMID: 8514334
  28. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome.
    Nature. 1993 Sep 16;365(6443):262-4 PMID: 8371781
  29. Selectivity of MHC-encoded peptide transporters from human, mouse and rat.
    Nature. 1994 Feb 17;367(6464):648-51 PMID: 8107849
  30. Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes.
    J Exp Med. 1994 Mar 1;179(3):901-9 PMID: 8113682
  31. Interferon-gamma induces different subunit organizations and functional diversity of proteasomes.
    J Biochem. 1994 Feb;115(2):257-69 PMID: 8206875
  32. Existence of a molecular ruler in proteasomes suggested by analysis of degradation products.
    FEBS Lett. 1994 Aug 1;349(2):205-9 PMID: 8050567
  33. Molecular cloning and expression of a gamma-interferon-inducible activator of the multicatalytic protease.
    J Biol Chem. 1994 Aug 12;269(32):20727-32 PMID: 8051173
  34. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Eur J Immunol. 1994 Aug;24(8):1863-8 PMID: 8056044
  35. MHC class I expression in mice lacking the proteasome subunit LMP-7.
    Science. 1994 Aug 26;265(5176):1234-7 PMID: 8066463
  36. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.
    Cell. 1994 Sep 9;78(5):761-71 PMID: 8087844
  37. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues.
    J Exp Med. 1994 Oct 1;180(4):1471-83 PMID: 7523572
  38. Effects of interferon gamma and major histocompatibility complex-encoded subunits on peptidase activities of human multicatalytic proteases.
    Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):584-8 PMID: 7831334
  39. Self peptides bound by HLA class I molecules are derived from highly conserved regions of a set of evolutionarily conserved proteins.
    Immunogenetics. 1995;41(5):257-62 PMID: 7536709
  40. Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution.
    Science. 1995 Apr 28;268(5210):533-9 PMID: 7725097
  41. Proteasome from Thermoplasma acidophilum: a threonine protease.
    Science. 1995 Apr 28;268(5210):579-82 PMID: 7725107
  42. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.
    Science. 1995 May 5;268(5211):726-31 PMID: 7732382
  43. Archaebacterial and eukaryotic proteasomes prefer different sites in cleaving gonadotropin-releasing hormone.
    J Biol Chem. 1995 May 12;270(19):11029-32 PMID: 7744730
  44. The peptide-binding domain of the chaperone protein Hsc70 has an unusual secondary structure topology.
    Biochemistry. 1995 May 16;34(19):6261-6 PMID: 7756251
  45. Altered peptidase and viral-specific T cell response in LMP2 mutant mice.
    Immunity. 1994 Oct;1(7):533-41 PMID: 7600282
  46. The three-dimensional structure of peptide-MHC complexes.
    Annu Rev Immunol. 1995;13:587-622 PMID: 7612235
  47. Evolutionary conservation of MHC class I and class II molecules--different yet the same.
    Semin Immunol. 1994 Dec;6(6):411-24 PMID: 7654997
  48. The interferon-gamma-inducible 11 S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro.
    J Biol Chem. 1995 Oct 6;270(40):23808-15 PMID: 7559557
  49. Incorporation of major histocompatibility complex--encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-gamma.
    Eur J Immunol. 1995 Sep;25(9):2605-11 PMID: 7589133
  50. New insights into V(D)J recombination and its role in the evolution of the immune system.
    Immunity. 1995 Nov;3(5):531-9 PMID: 7584143
  51. The first characterization of a eubacterial proteasome: the 20S complex of Rhodococcus.
    Curr Biol. 1995 Jul 1;5(7):766-74 PMID: 7583123
  52. Human lymphoblast and erythrocyte multicatalytic proteases: differential peptidase activities and responses to the 11S regulator.
    FEBS Lett. 1995 Dec 4;376(3):155-8 PMID: 7498531
  53. A role for the proteasome regulator PA28alpha in antigen presentation.
    Nature. 1996 May 9;381(6578):166-8 PMID: 8610016
  54. Effects of major-histocompatibility-complex-encoded subunits on the peptidase and proteolytic activities of human 20S proteasomes. Cleavage of proteins and antigenic peptides.
    Eur J Biochem. 1996 Jan 15;235(1-2):404-15 PMID: 8631360
  55. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway.
    Annu Rev Cell Dev Biol. 1995;11:267-306 PMID: 8689559
  56. Structural analysis of substrate binding by the molecular chaperone DnaK.
    Science. 1996 Jun 14;272(5268):1606-14 PMID: 8658133
  57. Isolation of low molecular mass polypeptide complementary DNA clones from primitive vertebrates. Implications for the origin of MHC class I-restricted antigen presentation.
    J Immunol. 1996 Jun 1;156(11):4245-53 PMID: 8666794
  58. Purification and characterization of the heat shock proteins HslV and HslU that form a new ATP-dependent protease in Escherichia coli.
    J Biol Chem. 1996 Jun 14;271(24):14035-40 PMID: 8662828
  59. Binding of viral antigens to major histocompatibility complex class I H-2Db molecules is controlled by dominant negative elements at peptide non-anchor residues. Implications for peptide selection and presentation.
    J Biol Chem. 1996 Jul 26;271(30):17829-36 PMID: 8663374
  60. Antigen processing and presentation by the class I major histocompatibility complex.
    Annu Rev Immunol. 1996;14:369-96 PMID: 8717519
  61. Paralogy mapping: identification of a region in the human MHC triplicated onto human chromosomes 1 and 9 allows the prediction and isolation of novel PBX and NOTCH loci.
    Genomics. 1996 Jul 1;35(1):101-8 PMID: 8661110
  62. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands.
    Cell. 1996 Jul 26;86(2):253-62 PMID: 8706130
  63. How selective is the transporter associated with antigen processing?
    Immunity. 1996 Jul;5(1):1-5 PMID: 8758889
  64. The proteolytic fragments generated by vertebrate proteasomes: structural relationships to major histocompatibility complex class I binding peptides.
    Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8572-7 PMID: 8710912
  65. Structure and functions of the 20S and 26S proteasomes.
    Annu Rev Biochem. 1996;65:801-47 PMID: 8811196
  66. Peptide antigen production by the proteasome: complexity provides efficiency.
    Immunol Today. 1996 Sep;17(9):429-35 PMID: 8854562
  67. Peptide selection for presentation by HLA class I: a role for the human transporter associated with antigen processing?
    Immunol Res. 1996;15(4):265-79 PMID: 8988395
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1997-07-21
Pages
209-20
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2198974
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com